FDA to Probe Safety of RSV Shot for Infants, Citing Deaths Reported in Clinical Trials
The agency plans to investigate two monoclonal antibody shots: Beyfortus, made by Sanofi and AstraZeneca, and Enflonsia, made by Merck. Both are currently recommended for most infants in the U.S.
Comments ()